比索洛尔治疗原发性高血压120例临床观察

目的：探讨比索洛尔对原发性高血压Ⅰ、Ⅱ级治疗的疗效。方法：120例原发性高血压患者用高度选择性β1受体阻滞剂索洛尔治疗,用药8周,对患者的血压、心率、降压疗效进行动态监测。结果：服药患者血压幅度及心率变化明显下降,120例患者中显效96例,占80%,有效17,占14%,总有效率为94%。用药后患者的血糖、血脂、电解质等指标与用药前相比较,无显著性差异。结论：在降低Ⅰ、Ⅱ级原发性高血压方面,比索洛尔具有较好的有效性和安全性。

Clinical observation on Bisoprolol in treatment of 120 cases primary hypertension

Objective：To Explore the Bisoprolol clinical therapeutic efficacy for primary hypertension grade Ⅰ,Ⅱ.Methods：120 patients with primary hypertension used highly-choice β1 receptor blocked Bisoprolol treatment for 8 weeks,Monitoring patients′ blood pressure,heart rate and blood pressure were monitored for dynamic.Results：Blood pressure and heart rate variability in patients decreased significantly.In 120 cases,there were 96 patients had effect（80%）.Effective cases of 17,accounting for 14%.The total effective rate was 94%.After treatment the blood glucose,lipids,electrolytes and other indicators,compared with the baseline,there was no significant change.Conclusion：In reducing hypertension Ⅰ,Ⅱ aspects,the Bisoprolol has good efficacy and safety.